Resultats de la cerca - Oomen‑deHoop, Esther
- Mostrar 1 - 20 resultats de 37
- Anar a la pàgina següent
-
1
Feasibility of Extrapolating Randomly Taken Plasma Samples to Trough Levels for Therapeutic Drug Monitoring Purposes of Small Molecule Kinase Inhibitors per van Eerden, Ruben A. G., Oomen-de Hoop, Esther, Noordam, Aad, Mathijssen, Ron H. J., Koolen, Stijn L. W.
Publicat 2021Text -
2
Locoregional control and survival after lymph node SBRT in oligometastatic disease per Loi, Mauro, Frelinghuysen, Michael, Klass, Natalie Desiree, Oomen-De Hoop, Esther, Granton, Patrick Vincent, Aerts, Joachim, Verhoef, Cornelis, Nuyttens, Joost
Publicat 2018Text -
3
Scopolaminebutyl given prophylactically for death rattle: study protocol of a randomized double-blind placebo-controlled trial in a frail patient population (the SILENCE study) per van Esch, Harriëtte J., van Zuylen, Lia, Oomen–de Hoop, Esther, van der Heide, Agnes, van der Rijt, Carin C. D.
Publicat 2018Text -
4
Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients per Mendelaar, Pauline A. J., Kraan, Jaco, Van, Mai, Zeune, Leonie L., Terstappen, Leon W. M. M., Oomen‐de Hoop, Esther, Martens, John W. M., Sleijfer, Stefan
Publicat 2020Text -
5
Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients per de Man, Femke M., van Eerden, Ruben A.G., Oomen-de Hoop, Esther, Veraart, Joris N., van Doorn, Nadia, van Doorn, Leni, van der Gaast, Ate, Mathijssen, Ron H.J.
Publicat 2019Text -
6
Influence of aprepitant and localization of the patch on fentanyl exposure in patients with cancer using transdermal fentanyl per Kuip, Evelien J.M., Oldenmenger, Wendy H., Visser-Thijs, Martine F., de Bruijn, Peter, Oomen-de Hoop, Esther, Mathijssen, Ron H.J., Van der Rijt, Carin C.D., Koolen, Stijn W.
Publicat 2018Text -
7
Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life: The SILENCE Randomized Clinical Trial per van Esch, Harriëtte J., van Zuylen, Lia, Geijteman, Eric C. T., Oomen-de Hoop, Esther, Huisman, Bregje A. A., Noordzij-Nooteboom, Heike S., Boogaard, Renske, van der Heide, Agnes, van der Rijt, Carin C. D.
Publicat 2021Text -
8
Effects of smoking and body mass index on the exposure of fentanyl in patients with cancer per Kuip, Evelien J. M., Oldenmenger, Wendy H., Thijs—Visser, Martine F., de Bruijn, Peter, Oosten, Astrid W., Oomen—de Hoop, Esther, Koolen, Stijn L. W., Van der Rijt, Carin C. D., Mathijssen, Ron H. J.
Publicat 2018Text -
9
Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study per van der Louw, Elles J. T. M., Olieman, Joanne F., van den Bemt, Patricia M. L. A., Bromberg, Jacoline E. C., Oomen-de Hoop, Esther, Neuteboom, Rinze F., Catsman-Berrevoets, Coriene E., Vincent, Arnaud J. P. E.
Publicat 2019Text -
10
Influence of Genetic Variation in COMT on Cisplatin-Induced Nephrotoxicity in Cancer Patients per Agema, Bram C., Koolen, Stijn L.W., de With, Mirjam, van Doorn, Nadia, Heersche, Niels, Oomen-de Hoop, Esther, Visser, Sabine, Aerts, Joachim G.J.V., Bins, Sander, van Schaik, Ron H.N., Mathijssen, Ron H.J.
Publicat 2020Text -
11
The added value of H(2) antagonists in premedication regimens during paclitaxel treatment per Cox, Juul M., van Doorn, Leni, Malmberg, Ruben, Oomen-de Hoop, Esther, Bosch, Tessa M., van den Bemt, Patricia M. L. A., Boere, Ingrid A., Jager, Agnes, Mathijssen, Ron H. J., van Leeuwen, Roelof W. F.
Publicat 2021Text -
12
High‐throughput isolation of circulating tumor DNA: a comparison of automated platforms per van Dessel, Lisanne F., Vitale, Silvia R., Helmijr, Jean C. A., Wilting, Saskia M., van der Vlugt‐Daane, Michelle, Oomen‐de Hoop, Esther, Sleijfer, Stefan, Martens, John W. M., Jansen, Maurice P. H. M., Lolkema, Martijn P.
Publicat 2018Text -
13
Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or Bioradiotherapy per Kuip, Evelien J. M., Oldenmenger, Wendy H., Oomen-de Hoop, Esther, Verduijn, Gerda M., Thijs-Visser, Martine F., de Bruijn, Peter, van Meerten, Esther, Koolen, Stijn L. W., Mathijssen, Ron H. J., van der Rijt, Carin C. D.
Publicat 2018Text -
14
Association between Paclitaxel Clearance and Tumor Response in Patients with Esophageal Cancer per Toxopeus, Eelke L.A., de Man, Femke M., Krak, Nanda, Biermann, Katharina, Nieuweboer, Annemieke J.M., Friberg, Lena E., Oomen-de Hoop, Esther, van Lanschot, Jan J.B., Shapiro, Joel, Wijnhoven, Bas P.L., Mathijssen, Ron H.J.
Publicat 2019Text -
15
Comparison of toxicity and effectiveness between fixed-dose and body surface area-based dose capecitabine per de Man, Femke M., Veerman, G.D. Marijn, Oomen-de Hoop, Esther, Deenen, Maarten J., Meulendijks, Didier, Mandigers, Caroline M.P.W., Soesan, Marcel, Schellens, Jan H.M., van Meerten, Esther, van Gelder, Teun, Mathijssen, Ron H.J.
Publicat 2019Text -
16
The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors per Hussaarts, Koen G. A. M., Berger, Florine A., Binkhorst, Lisette, Oomen - de Hoop, Esther, van Leeuwen, Roelof W. F., van Alphen, Robbert J., Mathijssen - van Stein, Daniëlle, de Groot, Natasja M. S., Mathijssen, Ron H. J., van Gelder, Teun
Publicat 2019Text -
17
Docetaxel Skin Exposure and Micronucleation Contributes to Skin Toxicity Caused by CPC634 per Atrafi, Florence, van Eerden, Ruben A. G., Koolen, Stijn L. W., de Bruijn, Peter, Rijcken, Cristianne J. F., Hanssen, Rob, Eskens, Ferry A. L. M., Lolkema, Martijn P., Oomen-de Hoop, Esther, Damman, Jeffrey, Mathijssen, Ron H. J.
Publicat 2021Text -
18
Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy per de With, Mirjam, Hurkmans, Daan P., Oomen-de Hoop, Esther, Lalouti, Ayoub, Bins, Sander, El Bouazzaoui, Samira, van Brakel, Mandy, Debets, Reno, Aerts, Joachim G. J. V., van Schaik, Ron H. N., Mathijssen, Ron H. J., van der Veldt, Astrid A. M.
Publicat 2021Text -
19
Decisional Conflict after Deciding on Potential Participation in Early Phase Clinical Cancer Trials: Dependent on Global Health Status, Satisfaction with Communication, and Timing per van Lent, Liza G. G., de Jonge, Maja J. A., van der Ham, Mirte, van Mil, Marjolein, Gort, Eelke H., Hasselaar, Jeroen, Oomen-de Hoop, Esther, van der Rijt, Carin C. D., van Weert, Julia C. M., Lolkema, Martijn P.
Publicat 2022Text -
20
Effects of prednisone on docetaxel pharmacokinetics in men with metastatic prostate cancer: A randomized drug–drug interaction study per Belderbos, Bodine P.S., Hussaarts, Koen G.A.M., van Harten, Leonie J., Oomen‐de Hoop, Esther, de Bruijn, Peter, Hamberg, Paul, van Alphen, Robbert J., Haberkorn, Brigitte C.M., Lolkema, Martijn P., de Wit, Ronald, van Soest, Robert J., Mathijssen, Ron H.J.
Publicat 2019Text